📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Intercell

1.1 - Company Overview

Intercell Logo

Intercell

Headquarter: Austria
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of vaccine design and development for prevention and treatment of infectious diseases, leveraging proprietary technology platforms to discover and develop antigens and adjuvants. Founded in 1998 and headquartered in Vienna, Austria.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Intercell

Tiziana Life Sciences Logo

Tiziana Life Sciences

HQ: United Kingdom Website
  • Description: Provider of biotechnology therapies focused on discovery and development of novel molecules in oncology and immunology, including Intranasal Foralumab (anti-CD3 nasal immunotherapy for neuroinflammatory and neurodegenerative diseases), Anti IL-6R mAb (TZLS-501) to reduce inflammation in idiopathic pulmonary fibrosis and autoimmune diseases, and Milciclib, a CDK-targeting cancer therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tiziana Life Sciences company profile →
Akari Therapeutics Logo

Akari Therapeutics

HQ: United Kingdom Website
  • Description: Provider of clinical-stage therapeutics focused on development and commercialization of innovative treatments, including nomacopan, a bispecific recombinant inhibitor targeting complement C5 and LTB4 for autoimmune and inflammatory diseases; a Phase 3 HSCT-TMA program for pediatric and adult transplant-related thrombotic microangiopathy; and PAS-nomacopan, a long-acting candidate for geographic atrophy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Akari Therapeutics company profile →
SuppreMol Logo

SuppreMol

HQ: Germany Website
  • Description: Provider of biotechnology therapies pioneering a novel approach to treat autoimmune diseases, aiming to cure these disorders rather than merely manage symptoms; privately held.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SuppreMol company profile →
Novavax Logo

Novavax

HQ: United States Website
  • Description: Provider of vaccines and vaccine technologies for infectious diseases, including a recombinant nanoparticle COVID-19 vaccine with Matrix-M adjuvant; a Phase 2 COVID-influenza combination (CIC) vaccine; and the authorized R21/Matrix-M malaria vaccine. Also offers Matrix-M, a saponin-based adjuvant, and recombinant nanoparticle vaccine technology using engineered proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Novavax company profile →
Celyad Oncology Logo

Celyad Oncology

HQ: Belgium Website
  • Description: Provider of cell therapy treatments for severe diseases in immuno-oncology and cardiology, developing CAR T-cell technologies and medical devices. Offers a multispecific CAR approach targeting NKG2D ligands plus another target to address resistance and immune escape, and shRNA multiplexing for non-gene edited CAR T cells. Pipeline includes CAR-T NKR-2, C-Cure, and CYAD-01/02/03.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Celyad Oncology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Intercell

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Intercell

2.2 - Growth funds investing in similar companies to Intercell

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Intercell

4.2 - Public trading comparable groups for Intercell

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Intercell

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Intercell

What does Intercell do?

Intercell is a provider of vaccine design and development for prevention and treatment of infectious diseases, leveraging proprietary technology platforms to discover and develop antigens and adjuvants. Founded in 1998 and headquartered in Vienna, Austria.

Who are Intercell's competitors?

Intercell's competitors and similar companies include Tiziana Life Sciences, Akari Therapeutics, SuppreMol, Novavax, and Celyad Oncology.

Where is Intercell headquartered?

Intercell is headquartered in Austria.

How many employees does Intercell have?

Intercell has 1,000 employees 🔒.

When was Intercell founded?

Intercell was founded in 2010 🔒.

What sector and industry vertical is Intercell in?

Intercell is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Intercell

Who are the top strategic acquirers in Intercell's sector and industry

Top strategic M&A buyers and acquirers in Intercell's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Intercell?

Top strategic M&A buyers groups and sectors for Intercell include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Intercell's sector and industry vertical

Which are the top PE firms investing in Intercell's sector and industry vertical?

Top PE firms investing in Intercell's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Intercell's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Intercell's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Intercell's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Intercell include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Intercell's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Intercell?

The key public trading comparables and valuation benchmarks for Intercell include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Intercell for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Intercell with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Intercell's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Intercell with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Intercell's' sector and industry vertical?

Access recent funding rounds and capital raises in Intercell's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Intercell